Predict SpAMIL:PRE +2.04%16 ROE % is 30.17% as of Dec. 2025, which is 279% above its 10-year median of 7.95. GuruFocus rates MIL:PRE with a GF Score™ of 16/100. The stock has 3 warning signs investors should review. Among 797 Medical Devices & Instruments companies, Predict SpA ranks better than 55.96% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Predict SpA's annualized net income for the quarter that ended in Dec. 2025 was €1.23 Mil. Predict SpA's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was €4.07 Mil. Therefore, Predict SpA's annualized ROE % for the quarter that ended in Dec. 2025 was 30.17%.
The historical rank and industry rank for Predict SpA's ROE % or its related term are showing as below:
MIL:PRE'
s ROE % Range Over the Past 10 Years
Min: 3.98 Med: 7.95 Max: 10.18
Current: 4.13
During the past 4 years, Predict SpA's highest ROE % was 10.18%. The lowest was 3.98%. And the median was 7.95%.
MIL:PRE's ROE % is ranked better than 55.96% of 797
companies
in the Medical Devices & Instruments industry
Industry Median: 2.4
vs MIL:PRE: 4.13
Predict SpA (MIL:PRE) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Predict SpA ROE % Related Terms
Predict SpA ROE % Historical Data
* Premium members only.
The historical data trend for Predict SpA's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Predict SpA's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Predict SpA ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Predict SpA's ROE % distribution charts can be found below:
* The bar in red indicates where Predict SpA's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Predict SpA (MIL:PRE) has a ROE % of 30.17% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Predict SpA and its competitors. This is 279% above median its historical median of 7.95. Over the past decade, Predict SpA's ROE % has ranged from 3.98 to 10.18. According to the industry distribution chart, Predict SpA ranks #351 out of 797 companies in the Medical Devices & Instruments industry, placing it in the top 44%.
Is Predict SpA's ROE % too high?
Predict SpA's current ROE % of 30.17% is 279% above median its 10-year median of 7.95. Over the past 10 years, this metric has ranged from a low of 3.98 to a high of 10.18. The Medical Devices & Instruments industry median ROE % is 2.40. Predict SpA's value of 30.17% is 1157.1% above this industry median. Based on the distribution chart, Predict SpA ranks #351 out of 797 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Predict SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Predict SpA's ROE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Predict SpA ranks #351 out of 797 companies for ROE %. This puts Predict SpA in the upper half of its industry. The industry median ROE % is 2.40. Predict SpA's value of 30.17% is 1157.1% above this benchmark. Historically, Predict SpA's own ROE % has ranged from 3.98 to 10.18 over the past decade. While the company's 10-year median is 7.95 vs. the industry median of 2.40, Predict SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.40, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Predict SpA's current ROE % of 30.17% is 1157.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Predict SpA and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Predict SpA's current ROE % is 30.17%, which is 279% above median its own 10-year median of 7.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Predict SpA stock overvalued right now?
Predict SpA (MIL:PRE) has a current ROE % of 30.17%. The current ROE % is 30.17%, which is 279% above median its 10-year median of 7.95 and 1157.1% above the Medical Devices & Instruments industry median of 2.40. Predict SpA's overall GF Score™ is 16/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Predict SpA (MIL:PRE), the current ROE % is 30.17% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Predict SpA develops innovative healthcare technologies, such as Optip and Mistral, and sells medical diagnostic imaging systems. Its products include Versana Active GE, Optic probe, Versana Balance GE, Voluson S-series, and Vivid T8.
16GF Score
Get the complete analysis for MIL:PRE
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:PRE has been successfully added to your 